Latest filing published 15 Jun 2026 for Biocryst Pharmaceuticals INC.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Theresa Heggie: trading record in brief
This profile gathers the share dealings of Theresa Heggie in Biocryst Pharmaceuticals Inc, where the filings describe the role as board member. We count 32 filings; the first trade dates from 1 September 2019 and the latest from 11 June 2026.
On the open market, the record shows 1 purchase worth €6,558 and 3 sales worth €983k. Netting one side against the other leaves €976k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 25 share grants and 3 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
Most recently, on 15 June 2026, the filings show a share grant in Biocryst Pharmaceuticals Inc. The last insider purchase was made public on 18 November 2019, 2,547 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Theresa Heggie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,294 sharesCommon StockSEC:0000882796-26-000035:0
- 49,933 shares@ US$6.300.016% mcap33.5% of flowCommon StockSEC:0000882796-26-000017:0
- 49,933 shares@ US$10.110.026% mcap53.7% of flowCommon StockSEC:0000882796-26-000017:1
- 30,000 shares@ US$2.918.6% of flowCommon StockSEC:0001127602-25-020491:0
- 12,500 shares0Common StockSEC:0001171843-25-003913:0
- 6,820 shares0Common StockSEC:0001127602-24-018715:0
- 870 shares@ US$6.460.6% of flowCommon StockSEC:0001127602-24-017302:0
- 999 shares@ US$5.630.6% of flowCommon StockSEC:0001127602-24-008140:0
- 956 shares@ US$5.880.6% of flowCommon StockSEC:0001127602-23-028607:0
- 791 shares@ US$7.110.6% of flowCommon StockSEC:0001127602-23-023693:0
- 16,745 shares0Common StockSEC:0001127602-23-018767:0
- 680 shares@ US$8.270.6% of flowCommon StockSEC:0001127602-23-017552:0
- 635 shares@ US$8.850.7% of flowCommon StockSEC:0001127602-23-008383:0
- 421 shares@ US$13.360.7% of flowCommon StockSEC:0001127602-22-026830:0
- 404 shares@ US$13.900.7% of flowCommon StockSEC:0001127602-22-022003:0
- 12,866 shares0Common StockSEC:0001127602-22-017157:0
- 1,138 shares@ US$9.310.0006% mcap16.0% of flowCommon StockSEC:0001127602-22-016402:0
- 602 shares@ US$16.611.0% of flowCommon StockSEC:0001127602-22-007722:0
- 829 shares@ US$12.061.0% of flowCommon StockSEC:0001127602-21-030052:0
- 628 shares@ US$15.921.0% of flowCommon StockSEC:0001127602-21-024774:0
- 317 shares@ US$15.770.5% of flowCommon StockSEC:0001127602-21-018474:0
21 of 21 declarations
